CIK 0001422143
- Non-accelerated filer
- Smaller reporting company
Kura Oncology, Inc.
Sign in to watch- Ticker
- KURA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 611547851
- Phone
- +1 858-500-8800
- Business address
- 4930 DIRECTORS PLACE, SUITE 500, SAN DIEGO, CA, 92121
- Former names
- ZETA ACQUISITION CORP III
- 4 Grant or award Chief Legal Officer acquired 46,250 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Gift President and CEO gave 3,000 shares (gift)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy Director bought 50,000 shares at $11.50 ($575,000)
- 4 Other disposition President and CEO disposed of 890,178 shares (other)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Grant or award SVP, Finance & Accounting acquired 10,625 shares (grant or award)
- 4 Grant or award Chief Legal Officer acquired 23,125 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Grant or award Chief Medical Officer acquired 23,125 shares (grant or award)
- 4 Other disposition President and CEO disposed of 1,623,608 shares (other)
- 4 Open-market sale Chief Operating Officer sold 1,821 shares at $13.89 ($25,294)
Page 6 of 14 · 277 filings